Works matching DE "ANTIBODY-toxin conjugates"
Results: 448
Understanding Evaluation and Management of Primary Cutaneous and Systemic ALCL.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 7, p. 594
- By:
- Publication type:
- Article
RelBE or not to be.
- Published in:
- Nature Structural & Molecular Biology, 2005, v. 12, n. 4, p. 282, doi. 10.1038/nsmb0405-282
- By:
- Publication type:
- Article
Cover Feature: <sup>64</sup>Cu tumor labeling with hexadentate picolinic acid‐based bispidine immunoconjugates (Chem. Eur. J. 32/2024).
- Published in:
- Chemistry - A European Journal, 2024, v. 30, n. 32, p. 1, doi. 10.1002/chem.202401745
- By:
- Publication type:
- Article
<sup>64</sup>Cu tumor labeling with hexadentate picolinic acid‐based bispidine immunoconjugates.
- Published in:
- Chemistry - A European Journal, 2024, v. 30, n. 32, p. 1, doi. 10.1002/chem.202400366
- By:
- Publication type:
- Article
Synthesis of Ursolic Acid Conjugates Containing a Furoxan Moiety.
- Published in:
- Chemistry of Natural Compounds, 2016, v. 52, n. 3, p. 555, doi. 10.1007/s10600-016-1708-2
- By:
- Publication type:
- Article
Local Treatment of Brain Tumors with Targeted Chimera Cytotoxic Proteins.
- Published in:
- Cancer Investigation, 2002, v. 20, n. 5/6, p. 801, doi. 10.1081/CNV-120003545
- By:
- Publication type:
- Article
Direct Retino-Raphe Projection Alters Serotonergic Tone and Affective Behavior.
- Published in:
- Neuropsychopharmacology, 2013, v. 38, n. 7, p. 1163, doi. 10.1038/npp.2013.35
- By:
- Publication type:
- Article
Targeting of Human Squamous Carcinomas by SPA470-doxorubicin Immunoconjugates.
- Published in:
- Journal of Drug Targeting, 2003, v. 11, n. 2, p. 101, doi. 10.1080/1061186031000121478
- By:
- Publication type:
- Article
Immunoconjugates: Current Status and Future Potential.
- Published in:
- 2002
- By:
- Publication type:
- Editorial
Identification of Anti-gp41 Monoclonal Antibodies That Effectively Target Cytotoxic Immunoconjugates to Cells Infected with Human Immunodeficiency Virus, Type 1.
- Published in:
- Vaccines, 2023, v. 11, n. 4, p. 829, doi. 10.3390/vaccines11040829
- By:
- Publication type:
- Article
Antibody-Drug Conjugates: Functional Principles and Applications in Oncology and Beyond.
- Published in:
- Vaccines, 2021, v. 9, n. 10, p. 1111, doi. 10.3390/vaccines9101111
- By:
- Publication type:
- Article
Bispecific Anti-HIV Immunoadhesins That Bind Gp120 and Gp41 Have Broad and Potent HIV-Neutralizing Activity.
- Published in:
- Vaccines, 2021, v. 9, n. 7, p. 774, doi. 10.3390/vaccines9070774
- By:
- Publication type:
- Article
In vitro and preclinical targeted alpha therapy of human prostate cancer with Bi-213 labeled J591 antibody against the prostate specific membrane antigen.
- Published in:
- Prostate Cancer & Prostatic Diseases, 2002, v. 5, n. 1, p. 36, doi. 10.1038/sj.pcan.4500543
- By:
- Publication type:
- Article
Nanobody-Based EGFR-Targeting Immunotoxins for Colorectal Cancer Treatment.
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 7, p. 1042, doi. 10.3390/biom13071042
- By:
- Publication type:
- Article
Effect of an immunotoxin to folate receptor β on bleomycin-induced experimental pulmonary fibrosis.
- Published in:
- Clinical & Experimental Immunology, 2010, v. 161, n. 2, p. 348, doi. 10.1111/j.1365-2249.2010.04182.x
- By:
- Publication type:
- Article
Essential role of toxin A in C. difficile 027 and reference strain supernatant-mediated disruption of Caco-2 intestinal epithelial barrier function.
- Published in:
- Clinical & Experimental Immunology, 2008, v. 153, n. 3, p. 439, doi. 10.1111/j.1365-2249.2008.03690.x
- By:
- Publication type:
- Article
A dominant linear B-cell epitope of ricin A-chain is the target of a neutralizing antibody response in Hodgkin's lymphoma patients treated with an anti-CD25 immunotoxin.
- Published in:
- Clinical & Experimental Immunology, 2004, v. 136, n. 2, p. 365, doi. 10.1111/j.1365-2249.2004.02442.x
- By:
- Publication type:
- Article
Identification of ricin A-chain HLA class II-restricted epitopes by human T-cell clones.
- Published in:
- Clinical & Experimental Immunology, 2001, v. 125, n. 3, p. 391, doi. 10.1046/j.1365-2249.2001.01525.x
- By:
- Publication type:
- Article
Characterization of the increased cytotoxicity of gelonin anti--T cell immunoconjugates compared with ricin A chain immunoconjugates.
- Published in:
- Clinical & Experimental Immunology, 1994, v. 97, n. 1, p. 10, doi. 10.1111/1365-2249.ep15987800
- By:
- Publication type:
- Article
A comparison of anti-lymphocyte immunotoxins containing different ribosome-inactivating proteins and antibodies.
- Published in:
- Clinical & Experimental Immunology, 1992, v. 89, n. 3, p. 341
- By:
- Publication type:
- Article
Potentiation of a weakly active ricin A chain immunotoxin recognizing the neural cell adhesion molecule.
- Published in:
- Clinical & Experimental Immunology, 1992, v. 89, n. 3, p. 336
- By:
- Publication type:
- Article
The selective cytotoxicity of cobra venom factor immunoconjugate on cultured human nasopharyngeal carcinoma cell line.
- Published in:
- Human & Experimental Toxicology, 1999, v. 18, n. 2, p. 71, doi. 10.1191/096032799678839716
- By:
- Publication type:
- Article
Targeted Therapy of Cancer: New Prospects for Antibodies and Immunoconjugates.
- Published in:
- CA: A Cancer Journal for Clinicians, 2006, v. 56, n. 4, p. 226, doi. 10.3322/canjclin.56.4.226
- By:
- Publication type:
- Article
Synthesis, characterization, and assessment of cytotoxic, antiproliferative, and antiangiogenic effects of a novel procainamide hydrochloride-poly (maleic anhydride-co-styrene) conjugate.
- Published in:
- Journal of Biomaterials Science -- Polymer Edition, 2013, v. 24, n. 10, p. 1260, doi. 10.1080/09205063.2012.750209
- By:
- Publication type:
- Article
Design of two immunotoxins based rovalpituzumab antibody against DLL3 receptor; a promising potential opportunity.
- Published in:
- Research in Pharmaceutical Sciences, 2022, v. 17, n. 4, p. 428, doi. 10.4103/1735-5362.350243
- By:
- Publication type:
- Article
Assessment of GM-CSF receptors by real--time RT-PCR on cell lines expressing high and low affinity receptors and their relation to cytotoxic effect of chimeric protein (StxA1-GM-CSF).
- Published in:
- DARU: Journal of Pharmaceutical Sciences, 2007, v. 15, n. 3, p. 151
- By:
- Publication type:
- Article
Role of transglutaminase 2 in celiac disease pathogenesis.
- Published in:
- Seminars in Immunopathology, 2012, v. 34, n. 4, p. 513, doi. 10.1007/s00281-012-0305-0
- By:
- Publication type:
- Article
Chimeric molecules for cancer therapy.
- Published in:
- 1998
- By:
- Publication type:
- Abstract
Development and characterization of novel photosensitizer : scFv conjugates for use in photodynamic therapy of cancer.
- Published in:
- Immunology, 2007, v. 120, n. 4, p. 512, doi. 10.1111/j.1365-2567.2006.02522.x
- By:
- Publication type:
- Article
Tumoricidal Activity and Side Effects of Radiolabeled Anti-NCAM [ 131 I]-Iodine-ERIC1 in Neuroblastoma-Bearing Mice.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 19, p. 10737, doi. 10.3390/ijms251910737
- By:
- Publication type:
- Article
Synthesis of an Anti-CD7 Recombinant Immunotoxin Based on PE24 in CHO and E. coli Cell-Free Systems.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 22, p. 13697, doi. 10.3390/ijms232213697
- By:
- Publication type:
- Article
Cathepsin X Activity Does Not Affect NK-Target Cell Synapse but Is Rather Distributed to Cytotoxic Granules.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 24, p. 13495, doi. 10.3390/ijms222413495
- By:
- Publication type:
- Article
Nanobody Based Dual Specific CARs.
- Published in:
- International Journal of Molecular Sciences, 2018, v. 19, n. 2, p. 403, doi. 10.3390/ijms19020403
- By:
- Publication type:
- Article
Drug Conjugates Such as Antibody Drug Conjugates (ADCs), Immunotoxins and Immunoliposomes Challenge Daily Clinical Practice.
- Published in:
- International Journal of Molecular Sciences, 2012, v. 13, n. 12, p. 16020, doi. 10.3390/ijms131216020
- By:
- Publication type:
- Article
Targeted toxins.
- Published in:
- Journal of Oncology Pharmacy Practice, 1999, v. 5, n. 4, p. 149, doi. 10.1191/107815599678840480
- By:
- Publication type:
- Article
Synergistic cytotoxicity of a prostate cancer-specific immunotoxin in combination with the BH3 mimetic ABT-737.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 3, p. 413, doi. 10.1007/s00262-017-2097-5
- By:
- Publication type:
- Article
Correction to: Characterization of the first fully human anti-TEM1 scFv in models of solid tumor imaging and immunotoxin-based therapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 2, p. 329, doi. 10.1007/s00262-017-2101-0
- By:
- Publication type:
- Article
Dianthin-30 or gelonin versus monomethyl auristatin E, each configured with an anti-calcitonin receptor antibody, are differentially potent in vitro in high-grade glioma cell lines derived from glioblastoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 9, p. 1217, doi. 10.1007/s00262-017-2013-z
- By:
- Publication type:
- Article
Characterization of the first fully human anti-TEM1 scFv in models of solid tumor imaging and immunotoxin-based therapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 3, p. 367, doi. 10.1007/s00262-016-1937-z
- By:
- Publication type:
- Article
Systemic delivery of chTNT-3/CpG immunoconjugates for immunotherapy in murine solid tumor models.
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 5, p. 511, doi. 10.1007/s00262-016-1813-x
- By:
- Publication type:
- Article
Novel angiogenin mutants with increased cytotoxicity enhance the depletion of pro-inflammatory macrophages and leukemia cells ex vivo.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 12, p. 1575, doi. 10.1007/s00262-015-1763-8
- By:
- Publication type:
- Article
ADAM17-overexpressing breast cancer cells selectively targeted by antibody-toxin conjugates.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 3, p. 411, doi. 10.1007/s00262-012-1346-x
- By:
- Publication type:
- Article
In vitro and in vivo effects of an anti-mouse endoglin (CD105)-immunotoxin on the early stages of mouse B16MEL4A5 melanoma tumours.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 3, p. 541, doi. 10.1007/s00262-012-1357-7
- By:
- Publication type:
- Article
Intratumoral delivery of CpG-conjugated anti-MUC1 antibody enhances NK cell anti-tumor activity.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 11, p. 2055, doi. 10.1007/s00262-012-1264-y
- By:
- Publication type:
- Article
In vivo imaging of immunotoxin treatment using Katushka-transfected A-431 cells in a murine xenograft tumour model.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 10, p. 1617, doi. 10.1007/s00262-012-1219-3
- By:
- Publication type:
- Article
Targeting of a developmentally regulated epitope of CD43 for the treatment of acute leukemia.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 12, p. 1697, doi. 10.1007/s00262-011-1066-7
- By:
- Publication type:
- Article
Use of CD40L immunoconjugates to overcome the defective immune response to vaccines for infections and cancer in the aged.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 12, p. 1949, doi. 10.1007/s00262-009-0718-3
- By:
- Publication type:
- Article
Targeting tumor-associated macrophages in an experimental glioma model with a recombinant immunotoxin to folate receptor β.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 10, p. 1577, doi. 10.1007/s00262-009-0667-x
- By:
- Publication type:
- Article
Preclinical studies in rats and squirrel monkeys for safety evaluation of the bivalent anti-human T cell immunotoxin, A-dmDT390–bisFv(UCHT1).
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 8, p. 1225, doi. 10.1007/s00262-008-0457-x
- By:
- Publication type:
- Article
Treatment of hepatocellular carcinoma in a mouse xenograft model with an immunotoxin which is engineered to eliminate vascular leak syndrome.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 11, p. 1775, doi. 10.1007/s00262-007-0321-4
- By:
- Publication type:
- Article